While glycine (M+3) abundance remained unaltered, SDH inhibition led to decreased abundance of IMP (M+3), AMP (M+3), and GMP (M+3) in colorectal and breast tumors (Fig. 2H and Supplementary Fig. 1J). This evidence concerns the gene SDHB and breast neoplasm.